In a study for acne vulgaris, sequence-based HLA typing showed a novel DPB1 allele, DPB1*2402

Area of Science:

• Immunogenetics
• Human Leukocyte Antigens (HLA)

Background:

• Acne vulgaris is a common skin condition with complex etiologies.
• Human Leukocyte Antigen (HLA) genes play a crucial role in immune responses.
• Specific HLA alleles have been associated with various dermatological conditions.

Purpose of the Study:

• To characterize a newly identified human leucocyte antigen (HLA)-DPB1*2402 allele.
• To investigate the genetic basis of the novel HLA-DPB1*2402 allele in a patient with acne vulgaris.

Main Methods:

• Sequence analysis of the HLA-DPB1 gene.
• Comparison of the novel allele with known HLA alleles, specifically DPB1*0401.
• Identification of nucleotide and amino acid substitutions.

Main Results:

• A novel HLA allele, designated HLA-DPB1*2402, was identified.
• The HLA-DPB1*2402 allele differs from HLA-DPB1*0401 by a single nucleotide exchange at position 115 (202), with thymine replacing guanine.
• This substitution results in a change at amino acid position 39, where tyrosine (TAC) replaces aspartic acid (GAC) in the novel allele.

Conclusions:

• The discovery of the HLA-DPB1*2402 allele provides new insights into HLA polymorphism.
• The specific genetic alteration in HLA-DPB1*2402 may have implications for immune responses in acne vulgaris.
• Further research is warranted to explore the functional significance of this novel HLA allele in disease pathogenesis.